(Q43236384)

English

Davalintide (AC2307), a novel amylin-mimetic peptide: enhanced pharmacological properties over native amylin to reduce food intake and body weight

scientific article published on 24 November 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Davalintide (AC2307), a novel amylin-mimetic peptide: enhanced pharmacological properties over native amylin to reduce food intake and body weight (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

1 reference

based on heuristic

inferred from title

James L Trevaskis

6

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

author name string

C M Mack

1

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

C J Soares

2

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

J K Wilson

3

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

J R Athanacio

4

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

V F Turek

5

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

J D Roth

7

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

P A Smith

8

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

B Gedulin

9

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

C M Jodka

10

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

B L Roland

11

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

S H Adams

12

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

A Lwin

13

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

J Herich

14

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

K D Laugero

15

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

C Vu

16

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

R Pittner

17

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

J R Paterniti

18

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

M Hanley

19

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

S Ghosh

20

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

D G Parkes

21

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

language of work or name

0 references

publication date

24 November 2009

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

International Journal of Obesity

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

34

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

385-395

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

https://scigraph.springernature.com/pub.10.1038/ijo.2009.238

0 references

Pramlintide, the synthetic analogue of amylin: physiology, pathophysiology, and effects on glycemic control, body weight, and selected biomarkers of vascular risk

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.238

21 January 2018

Pharmacological actions of the peptide hormone amylin in the long-term regulation of food intake, food preference, and body weight

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.238

21 January 2018

The anorectic hormone amylin contributes to feeding-related changes of neuronal activity in key structures of the gut-brain axis

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.238

21 January 2018

Amylin receptor blockade stimulates food intake in rats

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.238

21 January 2018

Amylin replacement with pramlintide as an adjunct to insulin therapy in type 1 and type 2 diabetes mellitus: a physiological approach toward improved metabolic control

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.238

7 January 2021

based on heuristic

inferred from DOI database lookup

Pramlintide in the treatment of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.238

7 January 2021

based on heuristic

inferred from DOI database lookup

Amylinergic control of food intake

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.238

7 January 2021

based on heuristic

inferred from DOI database lookup

Amylin receptors mediate the anorectic action of salmon calcitonin (sCT)

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.238

7 January 2021

based on heuristic

inferred from DOI database lookup

Amylin and food intake in mice: effects on motivation to eat and mechanism of action.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.238

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute 3rd-ventricular amylin infusion potently reduces food intake but does not produce aversive consequences

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.238

7 January 2021

based on heuristic

inferred from DOI database lookup

Lesion of the area postrema/nucleus of the solitary tract (AP/NTS) attenuates the anorectic effects of amylin and calcitonin gene-related peptide (CGRP) in rats

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.238

7 January 2021

based on heuristic

inferred from DOI database lookup

Amylin potently activates AP neurons possibly via formation of the excitatory second messenger cGMP.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.238

7 January 2021

based on heuristic

inferred from DOI database lookup

The anorectic effect of a chronic peripheral infusion of amylin is abolished in area postrema/nucleus of the solitary tract (AP/NTS) lesioned rats

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.238

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of Fos induced in rat brain by GLP-1 and amylin.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.238

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of central amylin signaling increases food intake and body adiposity in rats

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.238

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiobesity effects of the beta-cell hormone amylin in diet-induced obese rats: effects on food intake, body weight, composition, energy expenditure, and gene expression

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.238

7 January 2021

based on heuristic

inferred from DOI database lookup

Synergy between amylin and cholecystokinin for inhibition of food intake in mice

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.238

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination therapy with amylin and peptide YY[3-36] in obese rodents: anorexigenic synergy and weight loss additivity

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.238

7 January 2021

based on heuristic

inferred from DOI database lookup

Leptin responsiveness restored by amylin agonism in diet-induced obesity: evidence from nonclinical and clinical studies

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.238

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiobesity effects of the beta-cell hormone amylin in combination with phentermine or sibutramine in diet-induced obese rats

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.238

7 January 2021

based on heuristic

inferred from DOI database lookup

Pramlintide in the management of insulin-using patients with type 2 and type 1 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.238

7 January 2021

based on heuristic

inferred from DOI database lookup

Progressive reduction in body weight after treatment with the amylin analog pramlintide in obese subjects: a phase 2, randomized, placebo-controlled, dose-escalation study

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.238

7 January 2021

based on heuristic

inferred from DOI database lookup

Pramlintide treatment reduces 24-h caloric intake and meal sizes and improves control of eating in obese subjects: a 6-wk translational research study

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.238

7 January 2021

based on heuristic

inferred from DOI database lookup

Sustained weight loss following 12-month pramlintide treatment as an adjunct to lifestyle intervention in obesity

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.238

7 January 2021

based on heuristic

inferred from DOI database lookup

Salmon calcitonin - a potent inhibitor of food intake in states of impaired leptin signalling in laboratory rodents

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.238

7 January 2021

based on heuristic

inferred from DOI database lookup

Amylin receptors: molecular composition and pharmacology

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.238

7 January 2021

based on heuristic

inferred from DOI database lookup

Complexing receptor pharmacology: modulation of family B G protein-coupled receptor function by RAMPs

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.238

7 January 2021

based on heuristic

inferred from DOI database lookup

Calcitonin, calcitonin gene-related peptide, adrenomedullin and amylin: homologous peptides, separate receptors and overlapping biological actions.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.238

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential effects of amylin and salmon calcitonin on neuropeptide gene expression in the lateral hypothalamic area and the arcuate nucleus of the rat.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.238

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of pramlintide on satiety and food intake in obese subjects and subjects with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.238

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/IJO.2009.238

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43236384&oldid=1984441091"